XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Balance beginning of period (in shares) at Dec. 31, 2022   54,065,000      
Balance beginning of period at Dec. 31, 2022 $ 1,922,322 $ 541 $ 504,240 $ (167,181) $ 1,584,722
Increase (Decrease) in Stockholders' Equity          
Net income 72,401       72,401
Other comprehensive loss (14,346)     (14,346)  
Stock-based compensation 6,018   6,018    
Issuance of common stock for restricted share vesting, net of employee tax withholdings (in shares)   49,000      
Issuance of common stock for restricted share vesting, net of employee tax withholdings (3,351)   (3,351)    
Repurchases of common stock (in shares)   (22,000)      
Repurchases of common stock (3,000)   (3,000)    
Balance ending of period (in shares) at Mar. 31, 2023   54,092,000      
Balance ending of period at Mar. 31, 2023 $ 1,980,044 $ 541 503,907 (181,527) 1,657,123
Balance beginning of period (in shares) at Dec. 31, 2023 53,929,703 53,930,000      
Balance beginning of period at Dec. 31, 2023 $ 2,247,506 $ 539 459,728 (175,339) 1,962,578
Increase (Decrease) in Stockholders' Equity          
Net income 69,832       69,832
Other comprehensive loss (4,287)     (4,287)  
Stock-based compensation 6,338   6,338    
Issuance of common stock for restricted share vesting, net of employee tax withholdings (in shares)   23,000      
Issuance of common stock for restricted share vesting, net of employee tax withholdings (3,052)   (3,052)    
Repurchases of common stock (in shares)   (27,000)      
Repurchases of common stock $ (5,000)   (5,000)    
Balance ending of period (in shares) at Mar. 31, 2024 53,926,191 53,926,000      
Balance ending of period at Mar. 31, 2024 $ 2,311,337 $ 539 $ 458,014 $ (179,626) $ 2,032,410